Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation
about
The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.Beta-adrenergic receptors are expressed across diverse cancers.Propranolol suppresses the proliferation and induces the apoptosis of liver cancer cells.Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation.The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients
P2860
Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Beta-blockers improve survival ...... ma: a retrospective evaluation
@en
Beta-blockers improve survival ...... a: a retrospective evaluation.
@nl
type
label
Beta-blockers improve survival ...... ma: a retrospective evaluation
@en
Beta-blockers improve survival ...... a: a retrospective evaluation.
@nl
prefLabel
Beta-blockers improve survival ...... ma: a retrospective evaluation
@en
Beta-blockers improve survival ...... a: a retrospective evaluation.
@nl
P2093
P2860
P50
P356
P1476
Beta-blockers improve survival ...... ma: a retrospective evaluation
@en
P2093
Francis K Buadi
John A Lust
Nelson Leung
Prashant Kapoor
Shaji K Kumar
Wilson I Gonsalves
P2860
P356
10.1002/AJH.24582
P50
P577
2016-10-12T00:00:00Z